A Food and Drug Administration advisory panel narrowly rejected manufacturing of the peptide emideltide but recommended allowing pharmacies to make four other peptides, including epitalon.[5435635] The votes bring health secretary Robert F. Kennedy, Jr. closer to his mission of making unapproved compounds more available for Americans.[5435635]